As in skeletal muscle, NF-κB inhibition has been shown to ameliorate cardiac atrophy and functionality in a mouse model of Colon-26-driven cancer cachexia,91 suggesting novel therapeutic approaches for this severe cause of cancer-cachexia death. Here, NFKB1 is linked to cancer.